{"id":1558,"date":"2025-07-10T08:51:33","date_gmt":"2025-07-10T08:51:33","guid":{"rendered":"https:\/\/web.aimgroupinternational.com\/2026\/sclerosiscongress\/?page_id=1558"},"modified":"2025-09-25T09:53:39","modified_gmt":"2025-09-25T09:53:39","slug":"abstract-submission","status":"publish","type":"page","link":"https:\/\/web.aimgroupinternational.com\/2026\/sclerosiscongress\/abstract-submission\/","title":{"rendered":"Abstract Submission"},"content":{"rendered":"\t\t
\n\t\t\t\t
\n\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\"\"\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t
\n\t\t\t\t\t
\n\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t
\n\t\t\t\n\t\t\t\t\t\t<\/span>\n\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

Every breakthrough begins with a challenge<\/strong>.<\/p>

In science, as in sport, it takes courage to face the unknown and push beyond limits.<\/strong><\/p>

We believe researchers are the true athletes of science<\/strong>: women and men who overcome barriers and drive progress in the fight against scleroderma.<\/p>

Together, we celebrate every contribution<\/strong> and honour those who stand out as champions of progress.<\/p>

Submit your abstract<\/strong> and join us at the Systemic Sclerosis World Congress 2026 in Athens, Greece.<\/p>

Share your research, engage in discussion, and celebrate the spirit of discovery<\/strong> with colleagues from all over the world: take part in the first Scleroderma Champion Award<\/strong>, a competition that values teamwork and rewards excellence with a prestigious prize.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t

\n\t\t\t\t\t\t\t\t\t

The abstract submission is closed.<\/b><\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t

\n\t\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\tLATE BREAKING SUBMISSION<\/span>\n\t\t\t\t\t<\/span>\n\t\t\t\t\t<\/a>\n\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t
\n\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\"Champions\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t
\n\t\t\t\t\t
\n\t\t
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

Each paper must not exceed\u00a0400 words.
<\/strong>Only JPG files, up to 500KB, for\u00a0X Ray, CT scan, NMR, pictures of skin, fingers and so on\u00a0can be uploaded<\/strong>.
The abstract will be structured in single headings: Introduction, Material and Methods, Results and Conclusion<\/strong>.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t

\n\t\t\t\t\t

Deadlines<\/h2>\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

Abstract submission: Wednesday, September 10th<\/sup>, 2025 at 09:00 am CEST<\/del><\/strong> Extended until Monday, September 15th<\/sup> at 09:00 CEST<\/span>.<\/b>
Tentative notification to Authors:\u00a0End of November 2025
Early bird registration fee:\u00a0Monday, January 8, 2026<\/strong><\/strong><\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t

\n\t\t\t\t\t

Encore Abstracts<\/h2>\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

Encore abstracts are admitted but it is not allowed to submit the very same abstract presented elsewhere. It is important to have at least a new aspect and\/or analysis within more data or emphasis on different\/additional interpretation.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t

\n\t\t\t\t\t

Travel Bursaries<\/h2>\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

Kao Family Foundation \u2013 SCTC Young Investigator Travel Awards will be given to\u00a010<\/u>\u00a0eligible applicants with highly scored abstracts for participating in the<\/strong>\u00a0the 9th Systemic Sclerosis World Congress in Athens, Greece and the American College of Rheumatology Annual Convergence Meeting in Orlando, USA\u00a0 (November, 2026).<\/strong><\/p>

Amount:<\/strong>\u00a0$7,500 USD \u2013 Awards will be disbursed by the SCTC with $2,500 \u00a0given prior to the 9th<\/sup>\u00a0Systemic Sclerosis World Congress and $5,000 prior to the American College of Rheumatology Annual Convergence Meeting in 2026.<\/p>

Eligible applicants:\u00a0<\/strong>1) Clinical fellows; 2) Junior attendings that are in the 1st or 2nd year of practice at the time of application; 3) PhD students; 4) Postdoctoral researchers who are in the 1st or 2nd year of research since receiving their PhD at the time of application<\/p>

Additional eligibility criteria:
1. <\/strong>Applicant must be the first authorand<\/u> the presenting author of a highly scored abstract
2.<\/strong> Only one author per abstract may be considered for the award
3.<\/strong> In any given year, an individual institution is allowed only one awardee
4.<\/strong> Applicants are only able to be selected for a Kao Family- SCTC Travel Award once<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t

\n\t\t\t\t\t

Instruction to Authors<\/h2>\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t

The corresponding author is responsible for the abstract. Please note that only the corresponding author will receive mail concerning the abstract and is responsible for informing all co-authors of the status of the abstract. The corresponding author can be a first author or not.<\/p>

When the Scientific Committee will have evaluated all the papers received, the abstracts correspondents will receive all the information and necessary elements by mail.<\/p>

Accepted abstracts will be published on the \u201cJSRD<\/em>\u00a0\u2013\u00a0Journal of Scleroderma and Related Disorders\u201d<\/em>.<\/p>

Each abstract will be published as submitted. The organizers do not accept any responsibility for the accuracy of the abstracts.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t

\n\t\t\t\t\t

Topics<\/h2>\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t\t\t\t\t\t
  1. Pathogenesis \u2013 Genetics, environmental triggers, and the influence of gender<\/li>
  2. Pathogenesis \u2013 Fibrosis<\/li>
  3. Pathogenesis \u2013 Immune dysregulation, including autoantibodies<\/li>
  4. Pathogenesis \u2013 Vasculopathy<\/li>
  5. Interstitial lung disease<\/li>
  6. Pulmonary Hypertension<\/li>
  7. Heart<\/li>
  8. GI system<\/li>
  9. Raynaud and digital ulcers<\/li>
  10. Skin and localized scleroderma<\/li>
  11. Precision Medicine \u2013 including molecular and imaging studies<\/li>
  12. Innovative therapies, including cell therapies<\/li>
  13. Randomized Clinical Trials<\/li>
  14. Standard of care therapies<\/li>
  15. Patient perspective, including patient-reported outcomes<\/li>
  16. Pediatric scleroderma<\/li>
  17. Overlap syndromes<\/li>
  18. Miscellaneous<\/li><\/ol>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t
    \n\t\t\t\t\t\t\t
    \n\t\t\t
    <\/div>\n\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t
    \n\t\t\t\t\t\t\t\t\t

    For information about abstract submission please contact:<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t

    \n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\"\"\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t
    \n\t\t\t\t\t\t\t\t\t

    AIM Italy \u2013 Rome office
    <\/strong>Via Flaminia 1068 \u2013 00189 Rome, Italy
    Tel. +39 02 56601.1 \u2013 E-mail:\u00a0ssc2026.abstract@aimgroup.eu<\/a><\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t

    \n\t\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\tCLICK HERE TO SUBMIT YOUR ABSTRACT<\/span>\n\t\t\t\t\t<\/span>\n\t\t\t\t\t<\/a>\n\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t
    \n\t\t\t\t\t
    \n\t\t\t\t
    \n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t\"\"\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t","protected":false},"excerpt":{"rendered":"

    Every breakthrough begins with a challenge. In science, as in sport, it takes courage to face the unknown and push beyond limits. We believe researchers are the true athletes of science: women and men who overcome barriers and drive progress in the fight against scleroderma. Together, we celebrate every contribution and honour those who stand […]<\/p>\n","protected":false},"author":2,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_monsterinsights_skip_tracking":false,"_monsterinsights_sitenote_active":false,"_monsterinsights_sitenote_note":"","_monsterinsights_sitenote_category":0,"footnotes":""},"class_list":["post-1558","page","type-page","status-publish","hentry"],"_links":{"self":[{"href":"https:\/\/web.aimgroupinternational.com\/2026\/sclerosiscongress\/wp-json\/wp\/v2\/pages\/1558","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/web.aimgroupinternational.com\/2026\/sclerosiscongress\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/web.aimgroupinternational.com\/2026\/sclerosiscongress\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/web.aimgroupinternational.com\/2026\/sclerosiscongress\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/web.aimgroupinternational.com\/2026\/sclerosiscongress\/wp-json\/wp\/v2\/comments?post=1558"}],"version-history":[{"count":91,"href":"https:\/\/web.aimgroupinternational.com\/2026\/sclerosiscongress\/wp-json\/wp\/v2\/pages\/1558\/revisions"}],"predecessor-version":[{"id":1883,"href":"https:\/\/web.aimgroupinternational.com\/2026\/sclerosiscongress\/wp-json\/wp\/v2\/pages\/1558\/revisions\/1883"}],"wp:attachment":[{"href":"https:\/\/web.aimgroupinternational.com\/2026\/sclerosiscongress\/wp-json\/wp\/v2\/media?parent=1558"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}